Fungal infections and their treatment in the intensive care unit

George A. Sarosi

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

PURPOSE OF REVIEW: To describe and bring together recent development in the diagnosis and treatment of both community-acquired and opportunistic fungal infections in the intensive care unit. RECENT FINDINGS: The past few years have brought major advances to both the diagnosis and treatment of fungal infections. The development of newer therapeutic modalities to supplement existing treatment options includes a new class of antifungal agents, the echinocandins. Newer and improved agents of the azole class have arrived as well as better delineation for the role of liposomal amphotericins. Newer, nonculture-based diagnostic tests have allowed earlier, more timely diagnosis of opportunistic fungal infections, allowing more rapid initiation of therapy. SUMMARY: Improved diagnostic tests and newer antifungal agents have been introduced, leading to earlier diagnosis and treatment.

Original languageEnglish (US)
Pages (from-to)464-469
Number of pages6
JournalCurrent Opinion in Critical Care
Volume12
Issue number5
DOIs
StatePublished - Oct 1 2006

Keywords

  • Aspergillosis
  • Azoles
  • Candidiasis
  • Coccidioidomycosis
  • Echinocandins
  • Fungal infection

Fingerprint Dive into the research topics of 'Fungal infections and their treatment in the intensive care unit'. Together they form a unique fingerprint.

Cite this